HutchMED (China) LIMITED Selling Expense
HutchMED (China) LIMITED (HCM) reported Selling Expense of $36.31 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-03-05
- HutchMED (China) LIMITED selling expense for the quarter ending 2019-12-31 was $2.06M, a 49.40% decline year-over-year.
- HutchMED (China) LIMITED selling expense for the quarter ending 2019-09-30 was $4.16M, a 2.49% decline year-over-year.
- HutchMED (China) LIMITED selling expense for the quarter ending 2019-06-30 was $3.72M, a 22.21% decline year-over-year.
- HutchMED (China) LIMITED selling expense for the quarter ending 2019-03-31 was $3.79M, a 17.98% decline year-over-year.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $36.31M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $13.87M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $48.62M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $27.35M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $53.39M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $26.42M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $43.93M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $22.22M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $37.83M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $18.01M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $11.33M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $5.67M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $2.06M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $6.22M derived: sum of 2 quarters · filed 2022-03-03 | $9.94M derived: sum of 3 quarters · filed 2022-03-03 | $13.72M 20-F · filed 2022-03-03 |
| 2019-09-30 | $4.16M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $7.88M derived: sum of 2 quarters · filed 2020-07-30 | $11.66M 6-K · filed 2020-01-21 | $15.74M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $3.72M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $7.50M 6-K · filed 2020-07-30 | $11.58M derived: sum of 3 quarters · filed 2021-03-04 | $15.85M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $3.79M 6-K · filed 2019-06-06 | $7.86M derived: sum of 2 quarters · filed 2021-03-04 | $12.13M derived: sum of 3 quarters · filed 2021-03-04 | $16.91M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $4.08M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $8.34M derived: sum of 2 quarters · filed 2021-03-04 | $13.12M derived: sum of 3 quarters · filed 2021-03-04 | $17.74M 20-F · filed 2021-03-04 |
| 2018-09-30 | $4.26M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $9.04M derived: sum of 2 quarters · filed 2020-01-21 | $13.66M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $4.78M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $9.39M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $4.62M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $19.32M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $9.68M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $18.00M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $8.85M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $10.21M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $4.11M 20-F · filed 2017-03-13 |